Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nano-PROTACs: state of the art and perspectives
Jie Zhong, Ruiqi Zhao, Yuji Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 9, pp. 4378-4391
Closed Access | Times Cited: 12

Showing 12 citing articles:

PROTAC technology: From drug development to probe technology for target deconvolution
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 10
Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety
Renshuai Zhang, Songbo Xie, Jie Ran, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 9
PROTAC-Based Therapeutics for Targeting HPV Oncoproteins in Head and Neck Cancers
Nobendu Mukerjee, Dibyendu Mukherjee
Nano TransMed (2025), pp. 100071-100071
Open Access
Modulating the phosphorylation status of target proteins through bifunctional molecules
Qindi He, Zhijie Wang, Rongrong Wang, et al.
Drug Discovery Today (2025), pp. 104307-104307
Closed Access
New implications for prion diseases therapy and prophylaxis
Fangzhou Liu, Wenqi Lü, Ling Liu
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 5
Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple Negative Breast Cancer Treatment
Hongye He, Feng Li, Rui Tang, et al.
Biomaterials Research (2024) Vol. 2024
Open Access | Times Cited: 3
A Photoactivatable Upconverting Nanodevice Boosts Lysosomal Escape of PROTAC Degraders for Enhanced Combination Therapy
Jiayin Zhan, Xiang Li, Yueru Mu, et al.
Biomaterials Science (2024) Vol. 12, Iss. 14, pp. 3686-3699
Closed Access | Times Cited: 1
Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes
Janarthanan Venkatesan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, et al.
Pharmacology & Therapeutics (2024) Vol. 263, pp. 108725-108725
Closed Access | Times Cited: 1
Induction de proximité et dégradation de cibles thérapeutiques par les nouveaux dégradeurs : quels concepts, quels développements, quel futur ?
Michèle Reboud‐Ravaux
Biologie Aujourd hui (2024) Vol. 218, Iss. 1-2, pp. 41-54
Closed Access
Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design
Yu Chen, Fengyuan Liu, Samira Pal, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 19, pp. 9582-9608
Closed Access
Between Theory and Practice: Computational/Experimental Integrated Approaches to Understand the Solubility and Lipophilicity of PROTACs
Andrea Venturi, Stefano Di Bona, Jenny Desantis, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Exploring the Chemical Space of Mycobacterial Oxidative Phosphorylation Inhibitors Using Molecular Modeling
Islam K. Matar, Zhongmin Dong, Chérif F. Matta
ChemMedChem (2024) Vol. 19, Iss. 22
Open Access
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access
Page 1

Scroll to top